Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Rees

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
British Journal of Haematology|June 4, 2023
Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology GuidelineBarbara J Bain, Yvonne Daniel, Joan Henthorn, et al.
Haematologica|March 12, 2010
Extracranial internal carotid arterial disease in children with sickle cell anemiaColin R Deane, David Goss, Jack Bartram, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Validity of ligand efficiency metricsChristopher W Murray, Daniel A Erlanson, Andrew L Hopkins, et al.
American Journal of Hematology|July 8, 2022
The pleiotropic effects of α-thalassemia on HbSS and HbSC sickle cell disease: Reduced erythrocyte cation co-transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survivalJohn N Brewin, Amina Nardo-Marino, Sara Stuart-Smith, et al.
British Journal of Haematology|June 29, 2005
The measurement of urinary hydroxyurea in sickle cell anaemiaR Neil Dalton, Charles Turner, Moira Dick, et al.
British Journal of Haematology|July 13, 2017
The super sickling haemoglobin HbS-Oman: a study of red cell sickling, K<sup>+</sup> permeability and associations with disease severity in patients heterozygous for HbA and HbS-Oman (HbA/S-Oman genotype)Halima W M Al Balushi, Yasser Wali, Maha Al Awadi, et al.
British Journal of Haematology|January 14, 2010
Significant haemoglobinopathies: guidelines for screening and diagnosisKate Ryan, Barbara J Bain, David Worthington, et al.
Haematologica|March 17, 2018
Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarctionSanjay Tewari, George Renney, John Brewin, et al.
Plos One|June 8, 2018
A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemiaTitilope A Adeyemo, Oyesola O Ojewunmi, Idat A Oyetunji, et al.
Pediatric Blood & Cancer|September 25, 2015
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategyCarolyn C Hoppe, Lori Styles, Lori E Heath, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|June 4, 2023
Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology GuidelineBarbara J Bain, Yvonne Daniel, Joan Henthorn, et al.
Haematologica|March 12, 2010
Extracranial internal carotid arterial disease in children with sickle cell anemiaColin R Deane, David Goss, Jack Bartram, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Validity of ligand efficiency metricsChristopher W Murray, Daniel A Erlanson, Andrew L Hopkins, et al.
American Journal of Hematology|July 8, 2022
The pleiotropic effects of α-thalassemia on HbSS and HbSC sickle cell disease: Reduced erythrocyte cation co-transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survivalJohn N Brewin, Amina Nardo-Marino, Sara Stuart-Smith, et al.
British Journal of Haematology|June 29, 2005
The measurement of urinary hydroxyurea in sickle cell anaemiaR Neil Dalton, Charles Turner, Moira Dick, et al.
British Journal of Haematology|July 13, 2017
The super sickling haemoglobin HbS-Oman: a study of red cell sickling, K<sup>+</sup> permeability and associations with disease severity in patients heterozygous for HbA and HbS-Oman (HbA/S-Oman genotype)Halima W M Al Balushi, Yasser Wali, Maha Al Awadi, et al.
British Journal of Haematology|January 14, 2010
Significant haemoglobinopathies: guidelines for screening and diagnosisKate Ryan, Barbara J Bain, David Worthington, et al.
Haematologica|March 17, 2018
Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarctionSanjay Tewari, George Renney, John Brewin, et al.
Plos One|June 8, 2018
A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemiaTitilope A Adeyemo, Oyesola O Ojewunmi, Idat A Oyetunji, et al.
Pediatric Blood & Cancer|September 25, 2015
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategyCarolyn C Hoppe, Lori Styles, Lori E Heath, et al.
Pageof 18